In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin

Bull Exp Biol Med. 2018 Jun;165(2):220-224. doi: 10.1007/s10517-018-4134-6. Epub 2018 Jun 19.

Abstract

We studied combined effect of β-hairpin antimicrobial peptide tachyplesin I and cytotoxic agent cisplatin on tumor and normal human cell lines. MTT assay and flow cytometry showed that tachyplesin I selectively sensitized cancer cells to cisplatin in specified concentration ratios. In vitro experiments demonstrated that combined use of tachyplesin I and cisplatin allows decreasing the effective dose of the cytostatic thus reducing nonspecific toxicity.

Keywords: antimicrobial peptide; cisplatin; cytotoxicity; effective dose; tachyplesin.

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / pharmacology
  • Antimicrobial Cationic Peptides / administration & dosage
  • Antimicrobial Cationic Peptides / pharmacology*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacology*
  • DNA-Binding Proteins / administration & dosage
  • DNA-Binding Proteins / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Screening Assays, Antitumor
  • HEK293 Cells
  • HL-60 Cells
  • Humans
  • Neoplasms / pathology*
  • Peptides, Cyclic / administration & dosage
  • Peptides, Cyclic / pharmacology*

Substances

  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • DNA-Binding Proteins
  • Peptides, Cyclic
  • tachyplesin peptide, Tachypleus tridentatus
  • Cisplatin